Evidence map›Paper›PMID 36399523›Full record

ArticleBlood advances2023

Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load.

Devon J Eddins, Junkai Yang, Astrid Kosters, Vincent D Giacalone, Ximo Pechuan-Jorge, Joshua D Chandler, Jinyoung Eum, Benjamin R Babcock, Brian S Dobosh, Mindy R Hernández and 9 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The role of VISTA engagement in limiting neutrophil-mediated inflammation.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  11. Article
  12. De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Review
  14. Article
  15. Single-cell transcriptome analysis of the mouse lungs during the injury and recovery periods after lipopolysaccharide administration.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  16. Article
  17. Blocking HXAmBio · 2024
    Article
  18. Review
  19. Blocking HXAbioRxiv : the preprint server for biology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Devon J EddinsDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-7905-8306
Junkai YangDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-9147-5789
Astrid KostersDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-4771-5236
Vincent D GiacaloneDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-3496-7776
Ximo Pechuan-JorgeCancer Immunotherapy Discovery, Genentech, Inc., South San Francisco, CA.ORCID 0000-0001-8938-7931
Joshua D ChandlerDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-3211-7935
Jinyoung EumDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-6442-4126
Benjamin R BabcockDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.
Brian S DoboshDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-1537-7188
Mindy R HernándezDivision of Pulmonary, Department of Medicine, Allergy, Critical Care & Sleep Medicine, Emory University School of Medicine, Atlanta, GA.
Fathma AbdulkhaderDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.
Genoah L CollinsDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-4863-7516
Darya Y OrlovaCancer Immunotherapy Discovery, Genentech, Inc., South San Francisco, CA.
Richard P RamonellDivision of Pulmonary, Department of Medicine, Allergy, Critical Care & Sleep Medicine, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-2385-0636
Ignacio SanzDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.
Christine MoussionCancer Immunotherapy Discovery, Genentech, Inc., South San Francisco, CA.ORCID 0000-0002-1641-4094
F Eun-Hyung LeeDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.
Rabindra M TirouvanziamDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-3526-9985
Eliver E B GhosnDivision of Immunology and Rheumatology, Department of Medicine, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-7258-906X
Emory University · USGeorgia Institute of Technology · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
The Emory Training Program in Lung HealthT32HL116271 · NHLBI · EMORY UNIVERSITY · PI BROWN, LOU ANN S, GUIDOT, DAVID MARSHALL · 2013 to 2022
$4.2M
Integrin-dependent modulation of macrophage functionR01AI123126 · NIAID · EMORY UNIVERSITY · PI GHOSN, ELIVER · 2016 to 2020
$2.3M
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory UniversityS10OD026799 · OD · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD · 2019 to 2019
$985k
flowBEAT: a multiparameter flow cytometry assay to discover longitudinal antibody responses associated with efficient recovery from COVID-19R21AI167032 · NIAID · EMORY UNIVERSITY · PI GHOSN, ELIVER · 2022 to 2023
$425k
NHLBI NIH HHS T32 HL116271NIAID NIH HHS R01 AI123126NIAID NIH HHS R21 AI167032NIH HHS P51 OD011132NIH HHS S10 OD026799
6 · The paper itself

Abstract

Troubling disparities in COVID-19-associated mortality emerged early, with nearly 70% of deaths confined to Black/African American (AA) patients in some areas. However, targeted studies on this vulnerable population are scarce. Here, we applied multiomics single-cell analyses of immune profiles from matching airways and blood samples of Black/AA patients during acute SARS-CoV-2 infection. Transcriptional reprogramming of infiltrating IFITM2+/S100A12+ mature neutrophils, likely recruited via the IL-8/CXCR2 axis, leads to persistent and self-sustaining pulmonary neutrophilia with advanced features of acute respiratory distress syndrome (ARDS) despite low viral load in the airways. In addition, exacerbated neutrophil production of IL-8, IL-1β, IL-6, and CCL3/4, along with elevated levels of neutrophil elastase and myeloperoxidase, were the hallmarks of transcriptionally active and pathogenic airway neutrophilia. Although our analysis was limited to Black/AA patients and was not designed as a comparative study across different ethnicities, we present an unprecedented in-depth analysis of the immunopathology that leads to acute respiratory distress syndrome in a well-defined patient population disproportionally affected by severe COVID-19.

Indexed as

COVID-19Respiratory Distress SyndromeHumansInterleukin-8LungMembrane ProteinsNeutrophilsSARS-CoV-2Viral LoadIFITM2 protein, humanInterleukin-8Membrane Proteins

Identifiers

PMID36399523
PMCPMC9906672
OpenAlexW4309467805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.